AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


What if laboratories and clinicians had access to a testing platform that could rapidly diagnose bloodstream infections such as sepsis directly from blood samples within hours of a patient being admitted to the hospital? That was the idea behind Day Zero Diagnostics’ DZD OneSeq Dx platform. The Boston-based company received…
AACC has come out against using Ct values for managing patients with COVID-19. In a statement published in July 2021, AACC emphasized that SARS-CoV-2 tests are not standardized in any one country, let alone around the world. The same Ct value can therefore mean widely different things for different tests,…
In a session held at the 2021 AACC Annual Scientific Meeting, speakers explained how interoperability of electronic health records and systems can drive important research findings, how prediction models can be transferred across practices, and what labs can do to improve the quality of clinical prediction models.

Ask the Expert


Bench Matters


Federal Insider


In a letter to members of Congress, AACC warned legislators that several provisions in the Verifying Accurate Leading-edge IVCT Development Act could limit physician and patient access to state-of-the-art laboratory-developed tests.

Industry Playbook


Regulatory Roundup


The Sample